ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
2 hedge funds and large institutions have $6K invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 16 closing their positions.
89% less funds holding
Funds holding: 18 → 2 (-16)
99% less capital invested
Capital invested by funds: $813K → $6K (-$807K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$283 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$327K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$249K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$68K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$43K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$42K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Truist Financial
Charlotte,
North Carolina
| $5K | – | – | – |
|
|
AIM
2
Acrospire Investment Management
Chicago,
Illinois
| $1K | +$283 | +200 | +7% |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| – | -$327K | -251,837 | Closed |
|
|
4
HighTower Advisors
Chicago,
Illinois
| – | -$249K | -193,645 | Closed |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| – | -$68K | -52,333 | Closed |
|
|
VKH
6
Virtu KCG Holdings
New York
| – | -$43K | -32,783 | Closed |
|
|
7
Citadel Advisors
Miami,
Florida
| – | -$42K | -32,550 | Closed |
|
8
Renaissance Technologies
New York
| – | -$23K | -17,400 | Closed |
|
9
Northern Trust
Chicago,
Illinois
| – | -$16K | -12,493 | Closed |
|
10
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$13K | -10,158 | Closed |
|
11
UBS Group
Zurich,
Switzerland
| – | -$4K | -3,400 | Closed |
|
12
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| – | -$4K | -3,000 | Closed |
|
|
BFA
13
BlackRock Fund Advisors
San Francisco,
California
| – | -$2K | -1,709 | Closed |
|
14
US Bancorp
Minneapolis,
Minnesota
| – | -$1K | -1,000 | Closed |
|
15
Morgan Stanley
New York
| – | -$1K | -801 | Closed |
|
ECTE Hedge Fund Activity: Q3 2016 in Review
2 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q3 2016, worth a combined $6K — down 99% from $813K a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of ECTE and 0 opened new positions — a net loss of 16 holders — while 0 trimmed existing stakes and 1 added.
The largest buyer was Acrospire Investment Management, adding an estimated $283. The largest seller was Vanguard Group, exiting entirely with an estimated $327K sold.
- 2 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q3 2016, down from 18 in Q2 2016.
- Funds reported $6K of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q3 2016, down 99% quarter-over-quarter.
- 0 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q3 2016 and 16 closed out, a net change of -16 holders.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q3 2016 was Acrospire Investment Management, an estimated $283 added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q3 2016 was Vanguard Group, an estimated $327K sold.
Based on aggregated 13F filings for Q3 2016.